Fujifilm Medical Systems Europe Highlights AI Initiative in Austria

At FUJIFILM’s in-booth AI Center, visitors were offered live demonstrations of AI delivering enhanced workflows.

Under the REiLI brand, Fujifilm is developing AI technologies that strongly support diagnostic imaging workflow, leveraging the combination of deep learning in its AI technology with the company’s image processing heritage. The applications currently under development include: Region Recognition, an AI technology to accurately recognize and consistently extract organ regions, regardless of deviations in shape, presence or absence of disease, and imaging conditions; Computer Aided Detection, an AI technology to reduce the time of image interpretation and support radiologists' clinical decision making; Workflow Support, using AI technology to realize optimal study prioritization, alert communications of AI findings, and report population automation.

Fujifilm Healthcare’s IT platform showcased at ECR 2019 included its comprehensive medical informatics and enterprise-imaging portfolio, such as SYNAPSE 5, the next generation PACS and one of the fastest medical imaging solutions in the industry, offering sub second delivery of extremely large datasets; SYNAPSE VNA, the most secure, comprehensive application for storing and providing access to the complete imaging records; SYNAPSE MOBILITY Enterprise Viewer which uses the latest server-side rendering technology to stream imaging securely and quickly to any authorized user; SYNAPSE 3D, an enterprise-wide solution for quickly accessing 3D images and designed for use across multiple specialties, including radiology, cardiology, surgery and more; SYNAPSE CWM, a Clinical Workflow Manager and the most advanced radiology information system on the market today; and SYNCRO-DOSE, a radiation dose index monitoring system that is compliant with the Directive 2013/59/EURATOM of the European Union.